• Iron deficiency in patients with cardiogenic shock: protocol for a scoping review.

• The rolling stone: migration of an intrauterine device leading to bladder stone formation nine years after insertion: a case report.

• Iron Fortification and Inulin Supplementation in Early Infancy: Evaluating the Impact on Gut Microbiome in a Piglet Model.

• Facilitators and barriers to anemia prevention in the urban government childcare program for infants and young children in Peru.

• GFR is a Key Determinant of Red Blood Cell Survival in Anemia Associated With Progressive CKD.

• The effect of educational intervention based on the theory of planned behavior to prevent iron deficiency anemia in female high school students.

• Effects of Different Doses of Oral Iron on Hepcidin and Treatment Response in Iron Deficiency Anemia.

• Anemia, hematinic deficiencies, hyperhomocysteinemia, and gastric parietal cell antibody positivity in oral lichen planus patients with iron deficiency.

• Impact of Iron Deficiency Anemia on Postoperative Outcomes of Thoracolumbar Spinal Fusion (2+ levels) on Patients with Adult Spinal Deformity with Minimum 2-Year Follow-Up.

• Impact of inflammation on anemia in children: a cross-sectional study.

• The role of health literacy in the relationship between mothers' knowledge and practices of iron supplementation in children (aged 12 to 24 months): A structural equation model.

• Iron deficiency in infants and children - the current research challenges.

• Serum concentrations of per- and poly-fluoroalkyl substances (PFAS) in Danish pregnant women-temporal trends during pregnancy, correlations with partners, associations with physical activity, and blood lipid concentrations.

• Impact of preoperative anemia and perioperative transfusion on short-term outcomes in colorectal cancer surgery: The role of iron supplementation.

• Combined morphological and molecular approaches to the clinical diagnosis of Necator americanus infection: a case report.

• An unusual association: gastric xanthelasma presenting with iron deficiency anemia: a case report.

• Geophagia in pregnancy and its association with nutritional status - A prospective cohort study in rural north-eastern Tanzania.

• Iron insight: exploring dietary patterns and iron deficiency among teenage girls in Sweden.

• Impact of mass drug administration with ivermectin, diethylcarbamazine, and albendazole for lymphatic filariasis on hookworm and Strongyloides stercoralis infections in Papua New Guinea.

• An Examination of Iron-Deficiency Anemia and Its Associated Risk Factors Among Libyan Workers and Their Families.

• Comparative Assessment of Blood Parameters Including RBC, Hb, PCV, Red Cell Indices, Serum Ferritin, and Salivary Candidal Growth in Female Patients with Iron Deficiency Anemia and Iron Deficiency.

• A feasibility study of the internet-based intervention "Strategies for Empowering activities in Everyday life" (SEE 1.0) applied for people with stroke.

• Geophagy: uses and perceptions of women of childbearing age in Tshwane District, Gauteng Province-a qualitative study.

• Is an improvement in anaemia and iron levels associated with the risk of early postpartum depression? A cohort study from Lagos, Nigeria.

• Morphological and molecular evidence supporting advantages of apomictic seed production in castor bean (Ricinus communis L.).

• Safety and effectiveness of triple-drug therapy with ivermectin, diethylcarbamazine, and albendazole in reducing lymphatic filariasis prevalence and clearing circulating filarial antigens in Mombasa, Kenya.

• Serum hepcidin level with iron profile assay might replace bone marrow iron study as a diagnostic tool for evaluation of anemia in elderly without chronic renal disease.

• Postoperative day 1 discharge for segmentectomy using a minimally invasive approach after drain removal on the day of surgery.

• A real-world study on the characteristics of autoimmune gastritis: A single-center retrospective cohort in China.

• Iron intake and iron status of Swedish adolescents with diets of varying climate impact.

• Compliance with iron-folate supplementation among pregnant women in Southern Ethiopia: a multi-center cross-sectional study.

• Epidemiology of dietary iron deficiency in China from 1990 to 2021: findings from the global burden of disease study 2021.

• Correlation between blood parameters in the early and later stages of pregnancy: A retrospective study.

• Gene prediction of the relationship between iron deficiency anemia and immune cells.

• Optimal dose and duration of iron supplementation for treating iron deficiency anaemia in children and adolescents: A systematic review and meta-analysis.

• Iron deficiency and fatigue in inflammatory bowel disease: A systematic review

• Evaluating the cost-utility of ferric derisomaltose versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anaemia in Norway

• Evaluation of the potential use of protoporphyrins as biomarkers of anemic disease in human urine from inflammatory bowel disease patients

• Gut microbiota and intestinal rehabilitation: a prospective childhood cohort longitudinal study of short bowel syndrome (the MIRACLS study): study protocol

• BMI Status of Children with Celiac Disease Has Changed in the Last Decades: A 30-Year Retrospective Study

• Iron deficiency without anemia in children with newly diagnosed celiac disease: 1-year follow-up of ferritin levels, with and without iron supplementation

• Follow-up evaluation and management of anemia in inflammatory bowel disease: A study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD)

• Use of Biomarkers of Inflammation in the Differentiation of Iron Deficiency and Anaemia-Lessons from Inflammatory Bowel Disease

• AGA Clinical Practice Update on Management of Iron Deficiency Anemia: Expert Review

• Hypophosphatemia attenuates improvements in vitality after intravenous iron treatment in patients with inflammatory bowel disease

• Iron therapy supplementation in inflammatory bowel disease patients with iron deficiency anemia: findings from a real-world analysis in Italy

• Diagnosis and management of anemia in pediatric inflammatory bowel diseases: Clinical practice guidelines on behalf of the SIGENP IBD Working group

• Cost-utility analysis of ferric derisomaltose versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anemia in England

• Follow-up evaluation and management of anemia in inflammatory bowel disease: A study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD)

• Predicting response to iron supplementation in patients with active inflammatory bowel disease (PRIme): a randomised trial protocol

• Preoperative screening and prehabilitation strategies prior to ileocolic resection in patients with Crohn's disease are not incorporated in routine care

• The effect of iron therapy on oxidative stress and intestinal microbiota in inflammatory bowel diseases: A review on the conundrum

• Clinical Significance of Erythroferrone and Bone Morphogenetic Protein-6 in Patients with Anemia in the Course of Inflammatory Bowel Disease

• Iron deficiency anemia impacts disease progression and healthcare resource consumption in patients with inflammatory bowel disease: a real-world evidence study

• Ferric Carboxymaltose Versus Ferrous Fumarate in Anemic Children with Inflammatory Bowel Disease: The POPEYE Randomized Controlled Clinical Trial

• Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease (PHOSPHARE-IBD): a randomised clinical trial

• Anemia and Iron Deficiency in Outpatients with Inflammatory Bowel Disease: Ubiquitous Yet Suboptimally Managed

• A Systematic Review, Meta-Analysis, and Indirect Comparison of Blindly Adjudicated Cardiovascular Event Incidence with Ferric Derisomaltose, Ferric Carboxymaltose, and Iron Sucrose

• Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD

• Pathophysiology and therapeutic management of anemia in gastrointestinal disorders

• Ferric Carboxymaltose Improves the Quality of Life of Patients with Inflammatory Bowel Disease and Iron Deficiency without Anaemia

• Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational Study

• Iron Deficiency in Patients with Inflammatory Bowel Diseases: A Prospective Multicenter Cross-Sectional Study

• Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial

• Rapid priority setting exercise on faecal incontinence for Cochrane Incontinence

• ideline for the diagnosis and treatment of Faecal Incontinence-A UEG/ESCP/ESNM/ESPCG collaboration

• Safety profile of intravenous iron in inflammatory bowel disease: an up-to-date overview

• Questions and answers on iron deficiency treatment selection and the use of intravenous iron in routine clinical practice

• Effectiveness and safety of an on-demand ferric carboxymaltose infusion strategy in patients with inflammatory bowel disease: a real world experience

• Iron Deficiency Anemia and Hematochezia are Red Flags for Colorectal Cancer in Young Patients

• Utilization of an Electronic Medical Record-integrated Dashboard Improves Identification and Treatment of Anemia and Iron Deficiency in Pediatric Inflammatory Bowel Disease

• Iron Replacement Therapy with Oral Ferric Maltol: Review of the Evidence and Expert Opinion

• Skin Manifestations and Coeliac Disease in Paediatric Population

• Anemia Severity Associated with Increased Healthcare Utilization and Costs in Inflammatory Bowel Disease

• Diagnostic utility of low hemoglobin density to detect iron deficiency in patients with inflammatory bowel disease

• Impact of treatment of iron deficiency anemia in inflammatory bowel disease: considerations in managed care

• Diagnosis and management of iron deficiency anemia in inflammatory bowel disease

• The burden and management of anemia in Greek patients with inflammatory bowel disease: a retrospective, multicenter, observational study

• Evaluation of the Cost-Effectiveness of Iron Formulations for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease in the UK

• Sucrosomial Iron Supplementation for the Treatment of Iron Deficiency Anemia in Inflammatory Bowel Disease Patients Refractory to Oral Iron Treatment

• Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial

• Ferric carboxymaltose treatment for iron deficiency anemia in children with inflammatory bowel disease: Efficacy and risk of hypophosphatemia

• Iron deficiency anemia in IBD: an overlooked comorbidity

• Zinc Protoporphyrin Is a Reliable Marker of Functional Iron Deficiency in Patients with Inflammatory Bowel Disease

• Ferric maltol Real-world Effectiveness Study in Hospital practice (FRESH): clinical characteristics and outcomes of patients with inflammatory bowel disease receiving ferric maltol for iron-deficiency anaemia in the UK

• Interventions for treating iron deficiency anaemia in inflammatory bowel disease

• An Economic Analysis of Ferric Derisomaltose versus Ferric Carboxymaltose in the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease in Norway, Sweden, and Finland

• The Burden of Anemia Remains Significant over Time in Patients with Inflammatory Bowel Diseases at a Tertiary Referral Center

• Iron deficiency, depression, and fatigue in inflammatory bowel diseases

• Safety profile of intravenous iron in inflammatory bowel disease: an up-to-date overview

• Iron Therapy in Inflammatory Bowel Disease

• Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland

• Hypophosphatemia after Treatment of Iron Deficiency with Intravenous Ferric Carboxymaltose or Iron Isomaltoside - A Systematic Review and Meta-Analysis

• Utilization of an Electronic Medical Record-integrated Dashboard Improves Identification and Treatment of Anemia and Iron Deficiency in Pediatric Inflammatory Bowel Disease

• ANEMIA AND IRON DEFICIENCY IN INFLAMMATORY BOWEL DISEASE PATIENTS IN A REFERRAL CENTER IN BRAZIL: PREVALENCE AND RISK FACTORS

• Anemia in Children With Inflammatory Bowel Disease: A Position Paper by the IBD Committee of the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition

• Anemia Severity Associated with Increased Healthcare Utilization and Costs in Inflammatory Bowel Disease

• Portuguese Consensus on Diagnosis, Treatment, and Management of Anemia in Pediatric Inflammatory Bowel Disease

• Black Race and Public Insurance Are Predictive of Inappropriate Evaluation of Iron Deficiency Anemia and Diarrhea

• Trends in Anemia, Iron, Therapy, and Transfusion in Hospitalized Pediatric Patients With Inflammatory Bowel Disease

• Safety and Efficacy of Ferric Carboxymaltose in the Treatment of Iron Deficiency Anaemia in Patients With Inflammatory Bowel Disease, in Routine Daily Practice

• Inflammation, but Not the Underlying Disease or Its Location, Predicts Oral Iron Absorption Capacity in Patients With Inflammatory Bowel Disease

• Reticulocyte Hemoglobin and Hypochromic Erythrocytes in the Study of Erythropoiesis in Patients With Inflammatory Bowel Disease

• Improvement of Health-Related Quality of Life in Children with Inflammatory Bowel Disease Receiving Routine Intravenous Iron Supplementation

• Inflammation, but Not the Underlying Disease or Its Location, Predicts Oral Iron Absorption Capacity in Patients With Inflammatory Bowel Disease

• Incidence, Duration, and Management of Anemia: A Nationwide Comparison Between IBD and Non-IBD Populations

• Oral iron supplementation with Feralgine® in inflammatory bowel disease: a retrospective observational study

• Safety and Efficacy of Intravenous Iron Sucrose for Iron-Deficiency Anemia in Children and Adolescents With Inflammatory Bowel Disease

• Incidence of hypophosphatemia in patients with inflammatory bowel disease treated with ferric carboxymaltose or iron isomaltoside

• Management of Iron Deficiency Anaemia in Inflammatory Bowel Disease

• Anemia Screening, Prevalence, and Treatment in Pediatric Inflammatory Bowel Disease in the United States, 2010-2014

• Safety and efficacy of intravenous iron isomaltoside for correction of anaemia in patients with inflammatory bowel disease in everyday clinical practice

• Safety and Efficacy of Ferric Carboxymaltose in the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease, in Routine Daily Practice

• Diagnosis of chronic anaemia in gastrointestinal disorders: A guideline by the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) and the Italian Society of Paediatric Gastroenterology Hepatology and Nutrition (SIGENP)

• Treatment with Noripurum EV® is effective and safe in pediatric patients with inflammatory bowel disease and iron deficiency anemia

• Safety and efficacy of sucrosomial iron in inflammatory bowel disease patients with iron deficiency anemia

• Safety and efficacy of intravenous iron isomaltoside for correction of anaemia in patients with inflammatory bowel disease in everyday clinical practice

• Safety and Efficacy of Ferric Carboxymaltose in the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease, in Routine Daily Practice

• An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark

• The Relevance of Vitamin and Iron Deficiency in Patients with Inflammatory Bowel Diseases in Patients of the Swiss IBD Cohort.

• Practical guidance for the management of iron deficiency in patients with inflammatory bowel disease

• Inflammatory bowel disease and anemia: intravenous iron treatment

• Anemia in Pediatric Inflammatory Bowel Disease

• Managing iron deficiency and iron deficiency anemia in inflammatory bowel disease. The results of the the "Gestiona hierro-EII" survey

• Oral versus intravenous iron therapy in patients with inflammatory bowel disease and iron deficiency with and without anemia in Germany - a real-world evidence analysis

• Management of Anemia in Patients with Inflammatory Bowel Disease (IBD)

• Safety and efficacy of parenteral iron in children with inflammatory bowel disease

• Management of inflammatory bowel disease-related anemia and iron deficiency with specific reference to the role of intravenous iron in current practice

• Retrospective review of effectiveness and safety of intravenous ferric carboxymaltose given to children with iron deficiency anaemia in one UK tertiary centre

• Practical guidance for the management of iron deficiency in patients with inflammatory bowel disease

• Practical guidance for the management of iron deficiency in patients with inflammatory bowel disease

• The Relevance of Vitamin and Iron Deficiency in Patients with Inflammatory Bowel Diseases in Patients of the Swiss IBD Cohort

• Oral versus intravenous iron therapy in patients with inflammatory bowel disease and iron deficiency with and without anemia in Germany - a real-world evidence analysis

• Management of Anemia in Patients with Inflammatory Bowel Disease (IBD)

• Rational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease

• Should asymptomatic young men with iron deficiency anemia necessarily undergo endoscopy?

• Safety and efficacy of parenteral iron in children with inflammatory bowel disease

• A budget impact analysis of parenteral iron treatments for iron deficiency anemia in the UK: reduced resource utilization with iron isomaltoside 1000

• Management of inflammatory bowel disease-related anaemia and iron deficiency with specific reference to the role of intravenous iron in current practice

• INTRAVENOUS IRON TREATMENTS FOR IRON DEFICIENCY ANEMIA IN INFLAMMATORY BOWEL DISEASE: A BUDGET IMPACT ANALYSIS OF IRONISOMALTOSIDE 1000 (MONOFER) IN THE UK

• Endpoints for therapeutic interventions in faecal incontinence: small step or game changer

• Response of Iron Deficiency Anemia to Intravenous Iron Sucrose in Pediatric Inflammatory Bowel Disease

• Comparison of the Efficacies of Parenteral Iron Sucrose and Oral Iron Sulfate for Anemic Patients with Inflammatory Bowel Disease in Korea

• Intravenous Versus Oral Iron for the Treatment of Anemia in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

• Ferric maltol (ST10): a novel oral iron supplement for the treatment of iron deficiency anemia in inflammatory bowel disease

• Iron deficiency anemia in inflammatory bowel disease

• Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management

• Iron Replacement in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

• Diagnosis of Iron Deficiency in Inflammatory Bowel Disease by Transferrin Receptor-Ferritin Index

• Management of Iron-Deficiency Anemia in Inflammatory Bowel Disease: A Systematic Review

• Pharmacokinetics of Ferrous Sulphate (Tardyferon®) after Single Oral Dose Administration in Women with Iron Deficiency Anaemia

• Safety of ferric carboxymaltose immediately after infliximab administration, in a single session, in inflammatory bowel disease patients with iron deficiency: a pilot study

• A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel disease

• Iron Replacement in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

• Anemia in inflammatory bowel disease outpatients: prevalence, risk factors, and etiology

• Anemia in inflammatory bowel disease: an under-estimated problem?